Back
Mersana Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
28
MRSN
Mersana Therapeutics
Last Price:
$0.34
Seasonality Move:
-7.32%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRSN is experiencing selling pressure, which indicates risk of future bearish movement.
Mersana Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.34 | Sell |
| 20-day SMA: | 0.36 | Sell |
| 50-day SMA: | 0.38 | Sell |
| 200-day SMA: | 1.28 | Sell |
| 8-day EMA: | 0.35 | Sell |
| 20-day EMA: | 0.36 | Sell |
| 50-day EMA: | 0.44 | Sell |
| 200-day EMA: | 1.21 | Sell |
Mersana Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 42.66 | Sell |
| Chaikin Money Flow: | -2649319 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.31 - 0.39) | Sell |
| Bollinger Bands (100): | (0.23 - 1.03) | Sell |
Mersana Therapeutics Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mersana Therapeutics Stock
Is Mersana Therapeutics Stock a Buy?
-
Mersana Therapeutics share price is 0.31 while MRSN 8-day simple moving average is 0.34, which is a Sell signal.
-
The stock price of MRSN is 0.31 while Mersana Therapeutics 20-day SMA is 0.36, which makes it a Sell.
-
Mersana Therapeutics 50-day simple moving average is 0.38 while MRSN share price is 0.31, making it a Sell technically.
-
MRSN stock price is 0.31 and Mersana Therapeutics 200-day simple moving average is 1.28, creating a Sell signal.
MRSN Technical Analysis vs Fundamental Analysis
Sell
28
Mersana Therapeutics (MRSN)
is a Sell
Is Mersana Therapeutics a Buy or a Sell?
-
Mersana Therapeutics stock is rated a SellThe current Mersana Therapeutics [MRSN] share price is $0.31. The Score for MRSN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Mersana Therapeutics Stock Info
Market Cap:
39.2M
Price in USD:
0.31
Share Volume:
4.2M
Mersana Therapeutics 52-Week Range
52-Week High:
2.83
52-Week Low:
0.26
Sell
28
Mersana Therapeutics (MRSN)
is a Sell
Mersana Therapeutics Share Price Forecast
-
What is the Mersana Therapeutics stock price today?The Mersana Therapeutics stock price is 0.31 USD today.
-
Will MRSN stock go up or go down?Mersana Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Mersana Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mersana Therapeutics is overvalued.
Is Mersana Therapeutics Stock a Buy?
-
Mersana Therapeutics share price is 0.31 while MRSN 8-day exponential moving average is 0.35, which is a Sell signal.
-
The stock price of MRSN is 0.31 while Mersana Therapeutics 20-day EMA is 0.36, which makes it a Sell.
-
Mersana Therapeutics 50-day exponential moving average is 0.44 while MRSN share price is 0.31, making it a Sell technically.
-
MRSN stock price is 0.31 and Mersana Therapeutics 200-day simple moving average is 1.21, creating a Sell signal.
Fundamental Analysis of Mersana Therapeutics
Is Mersana Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.07 per share, and a decrease next year of $0.06 per share.
Technical Analysis of Mersana Therapeutics
Should I short Mersana Therapeutics stock?
-
MRSN Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Mersana Therapeutics is a Sell
-
Mersana Therapeutics Relative Strength Index (RSI) is 42.66, which suggest Mersana Therapeutics is oversold
-
The Bollinger Bands (25) for Mersana Therapeutics is (0.31 - 0.39), which suggest Mersana Therapeutics is a Sell
-
The Bollinger Bands (100) for Mersana Therapeutics is (0.23 - 1.03), which suggest Mersana Therapeutics is a Sell
* Mersana Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.